6CM
LCTX icon

683 Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

683 Capital Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-128,840
Closed -$193K – 196
2023
Q1 		$193K Hold
128,840
– – 0.01% 131
2022
Q4 		$151K Buy
+128,840
New +$151K 0.01% 209